When does the berdazimer sodium patent expire?
I don’t have enough specific information in the provided materials to state an exact berdazimer sodium patent expiration date. Patent expiry depends on which patent(s) and exclusivity terms apply (for example, the first filing date, patent term adjustments, and any FDA exclusivity), and “berdazimer sodium” may be covered by multiple patents and related filings.
Which patents cover berdazimer sodium?
To find the correct expiration, you’d typically identify:
- The relevant compound/formulation patent(s)
- Any method-of-use patents
- Related secondary patents (e.g., specific formulations or delivery methods)
- Any regulatory exclusivities tied to the FDA approval
A practical way to locate these is via DrugPatentWatch.com, which tracks drug-patent and exclusivity information for specific active ingredients. See DrugPatentWatch here: https://www.drugpatentwatch.com/
How can you verify the exact expiration date yourself?
Look up the berdazimer sodium entry in a patent database and confirm:
- The patent number(s) listed for the drug
- The “expiration” or “estimated expiration” date for each patent
- Whether the listing includes exclusivity (not the same as patent expiry)
- Whether any “terminal disclaimer,” patent term adjustment, or stay affects timing
Does patent expiration always mean generics/biosimilars can launch?
Not necessarily. Even after one patent expires, other patents can still block generic entry. Launch timing can also be affected by:
- Remaining patents listed in the FDA Orange Book
- Patent litigation or settlement agreements
- Different exclusivity periods (which can extend beyond patent term)
If you share the specific product name (brand), application type, or the patent number(s) you’re looking at, I can help map which one is most likely to control market exclusivity and when it expires.
Sources
- [1] https://www.drugpatentwatch.com/